Bayforest Capital’s AMN Healthcare AMN Stock Holding History

Bayforest Capital’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,234	Closed	-$77.4K	–	723
2024 Q4	$77.4K	Buy	+3,234	New	+$103K	0.1%	372

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayforest Capital's AMN Position: Q1 2025 in Review

Bayforest Capital sold out of AMN Healthcare (AMN) in Q1 2025, closing a stake of 3,234 shares — an estimated $77.4K sold.

Bayforest Capital first reported a position in AMN in Q4 2024 and held it in 1 quarter. The position peaked at $77.4K in Q4 2024. 292 funds tracked by Wall St. Rank hold AMN as of Q1 2025.

Bayforest Capital reported no remaining AMN Healthcare position as of Q1 2025 after selling out during the quarter.
Bayforest Capital sold 3,234 AMN Healthcare shares in Q1 2025, an estimated $77.4K.
Bayforest Capital first reported a position in AMN Healthcare in Q4 2024 and held it in 1 quarter.
Bayforest Capital's AMN Healthcare position peaked at $77.4K in Q4 2024.
292 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2025.

Based on Bayforest Capital's 13F filing for Q1 2025, filed 8 May 2025.